Skip to main content
. 2021 Dec 22;74(1):142–150. doi: 10.1002/acr.24421

Table 3.

Components of informed decision‐making and proximal outcome variables by assignment to the SMART or no SMART program groups*

Outcome variable, by follow‐up time period† SMART program Difference (95% CI) P
Yes No
Not using any DMARDs, % (no.)
6‐week 10.6 (15) 7.8 (11) 2.8 (–3.9, 9.5) 0.42
3‐month 11.9 (17) 7.7 (11) 4.3 (–2.6, 11.2) 0.22
6‐month 10.9 (16) 7.7 (11) 3.2 (–3.5, 9.9) 0.35
Knowledge
6‐week 81.4 ± 0.8 80.6 ± 0.7 0.9 (–1.2, 2.9) 0.42
3‐month 83.8 ± 0.8 81.8 ± 0.7 2.0 (–0.1, 4.1) 0.06
6‐month 84.0 ± 0.7 81.7 ± 0.7 2.2 (0.3, 4.2) 0.03
Values
6‐week 5.6 ± 0.3 5.3 ± 0.3 0.4 (–0.5, 1.2) 0.39
3‐month 5.4 ± 0.4 6.0 ± 0.3 –0.6 (–1.5. 0.4) 0.24
6‐month 5.7 ± 0.3 5.9 ± 0.3 –0.3 (–1.1, 0.6) 0.55
Gist reasoning ability
Complex abstraction
6‐week 1.8 ± 0.2 1.8 ± 0.1 0.04 (–0.4, 0.5) 0.87
3‐month 2.2 ± 0.2 1.7 ± 0.1 0.5 (0.1, 0.9) 0.02
6‐month 1.8 ± 0.2 2.0 ± 0.1 –0.10 (–0.5, 0.3) 0.53
Lesson quality
6‐week 0.9 ± 0.1 0.9 ± 0.1 0.04 (–0.3, 0.4) 0.79
3‐month 1.2 ± 0.1 0.9 ± 0.1 0.30 (–0.0, 0.6) 0.08
6‐month 1.0 ± 0.2 1.1 ± 0.1 –0.04 (–0.4, 0.3) 0.86
Information seeking, % (no.)
Viewed RA self‐management website 15.2 (22) 22.3 (32) –7.1 (–16.1, 1.9) 0.14
Participated in BetterChoices, BetterHealth 15.2 (22) 21.0 (30) –5.9 (–14.8, 3.1) 0.21
*

Values are the adjusted mean ± SE, unless indicated otherwise. All mean values are adjusted for the baseline value of the dependent variable and group assignment. For use of disease‐modifying antirheumatic drugs (DMARDs), raw percentages are shown. Frequencies and percentages are averaged across 50 imputations used to estimate values for missing data. The average frequencies are rounded to the nearest integer. 95% CI = 95% confidence interval; RA = rheumatoid arthritis; SMART = Strategic Memory Advanced Reasoning Training.